Related references
Note: Only part of the references are listed.Feasibility and Consistency of Results with Deployment of an In-Line Filter for Exercise-Based Evaluations of Patients With Heart Failure During the Novel Coronavirus Disease-2019 Pandemic
Rohan R. Bhat et al.
JOURNAL OF CARDIAC FAILURE (2021)
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
William T. Abraham et al.
EUROPEAN HEART JOURNAL (2021)
OUTSTEP-HF: randomised controlled trial comparing short-term effects of sacubitril/valsartan versus enalapril on daily physical activity in patients with chronic heart failure with reduced ejection fraction
Massimo F. Piepoli et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
Carlos G. Santos-Gallego et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
John R. Teerlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF
John R. Teerlink et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Use of Actigraphy (Wearable Digital Sensors to Monitor Activity) in Heart Failure Randomized Clinical Trials: A Scoping Review
Khalil Anchouche et al.
CANADIAN JOURNAL OF CARDIOLOGY (2021)
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)
Matthew M. Y. Lee et al.
CIRCULATION (2021)
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction Rationale and Design of GALACTIC-HF
John R. Teerlink et al.
JACC-HEART FAILURE (2020)
Heart Failure Clinical Trial Operations During the COVID-19 Pandemic Results From a Multicenter Survey
Marc D. Samsky et al.
CIRCULATION-HEART FAILURE (2020)
Conduct of Clinical Trials in the Era of COVID-19 JACC Scientific Expert Panel
Mitchell A. Psotka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Cardiac Calcitropes, Myotropes, and Mitotropes JACC Review Topic of the Week
Mitchell A. Psotka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Clinical Implications of the New York Heart Association Classification
Cesar Caraballo et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
6-minute walking test: a useful tool in the management of heart failure patients
Sophia Giannitsi et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2019)
Exercise Intolerance in Heart Failure With Preserved Ejection Fraction Diagnosing and Ranking Its Causes Using Personalized O2 Pathway Analysis
Nicholas E. Houstis et al.
CIRCULATION (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
Vicente J. Planelles-Herrero et al.
NATURE COMMUNICATIONS (2017)
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
Dirk J. van Veldhuisen et al.
CIRCULATION (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction Clinical Correlates and Association With Standard Heart Failure Severity Indices
David Snipelisky et al.
CIRCULATION-HEART FAILURE (2017)
Heart Failure: Exercise-Based Cardiac Rehabilitation: Who, When, and How Intense?
Mark J. Haykowsky et al.
CANADIAN JOURNAL OF CARDIOLOGY (2016)
Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure
Rajeev Malhotra et al.
CIRCULATION-HEART FAILURE (2016)
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2016)
Association between Objectively Measured Physical Activity and Mortality in NHANES
Ezra I. Fishman et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2016)
Cardiopulmonary Exercise Testing in Heart Failure
Rajeev Malhotra et al.
JACC-HEART FAILURE (2016)
Correlation of the New York Heart Association Classification and the 6-Minute Walk Distance: A Systematic Review
Jonathan Yap et al.
CLINICAL CARDIOLOGY (2015)
Pacemaker Quantified Physical Activity Predicts All-Cause Mortality
Sudhi Tyagi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Safety and Tolerability of Omecamtiv Mecarbil During Exercise in Patients With Ischemic Cardiomyopathy and Angina
Barry H. Greenberg et al.
JACC-HEART FAILURE (2015)
Physical Activity Measured With Implanted Devices Predicts Patient Outcome in Chronic Heart Failure
Viviane M. Conraads et al.
CIRCULATION-HEART FAILURE (2014)
An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease
Anne E. Holland et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures
Olatz Garin et al.
HEART FAILURE REVIEWS (2014)
Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: An individual patient's data meta-analysis of randomized controlled trials
Francesco Giallauria et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Iron deficiency in chronic heart failure: An international pooled analysis
IJsbrand T. Klip et al.
AMERICAN HEART JOURNAL (2013)
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND
Frank P. Brouwers et al.
EUROPEAN HEART JOURNAL (2013)
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Margaret M. Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction Prevalence, Therapies, and Outcomes
Benjamin A. Steinberg et al.
CIRCULATION (2012)
Modest Increase in Peak VO2 Is Related to Better Clinical Outcomes in Chronic Heart Failure Patients Results From Heart Failure and a Controlled Trial to Investigate Outcomes of Exercise Training
Ann M. Swank et al.
CIRCULATION-HEART FAILURE (2012)
World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult-a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation
James C. Fang et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
Association of Physical Activity and Prognostic Parameters in Elderly Patients With Heart Failure
Melissa Jehn et al.
JOURNAL OF AGING AND PHYSICAL ACTIVITY (2011)
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
John G. F. Cleland et al.
LANCET (2011)
Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Fady I. Malik et al.
SCIENCE (2011)
Reproducibility of Peak Oxygen Uptake and Other Cardiopulmonary Exercise Parameters Implications for Clinical Trials and Clinical Practice
Steven J. Keteyian et al.
CHEST (2010)
Clinician's Guide to Cardiopulmonary Exercise Testing in Adults A Scientific Statement From the American Heart Association
Gary J. Balady et al.
CIRCULATION (2010)
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
Marco Metra et al.
EUROPEAN HEART JOURNAL (2009)
Accelerometer-Based Quantification of 6-Minute Walk Test Performance in Patients With Chronic Heart Failure: Applicability in Telemedicine
Melissa Jehn et al.
JOURNAL OF CARDIAC FAILURE (2009)
Impact of Cardiac Contractility Modulation on Left Ventricular Global and Regional Function and Remodeling
Cheuk-Man Yu et al.
JACC-CARDIOVASCULAR IMAGING (2009)
Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in Systolic heart failure with QRS prolongation: COMPANION trial sub-study
Teresa De Marco et al.
JOURNAL OF CARDIAC FAILURE (2008)
Time course of effects of cardiac resynchronization therapy in chronic heart failure:: Benefits in patients with preserved exercise capacity
Massimo F. Piepoli et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2008)
Cardiac-resynchronization therapy in heart failure with narrow QRS complexes
John F. Beshai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Activity monitoring in heart failure patients with cardiac resynchronization therapy
Mihoko Kawabata et al.
CIRCULATION JOURNAL (2007)
Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association
William L. Haskell et al.
MEDICINE & SCIENCE IN SPORTS & EXERCISE (2007)
Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments
Mikhail Kosiborod et al.
CIRCULATION (2007)
Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure
Claire Raphael et al.
HEART (2007)
Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure
Uri Elkayam et al.
AMERICAN HEART JOURNAL (2007)
Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones
MU Braun et al.
HEART (2005)
Spironolactone improves lung diffusion in chronic heart failure
P Agostoni et al.
EUROPEAN HEART JOURNAL (2005)
Prognostic value of health status in patients with heart failure after acute myocardial infarction
GE Soto et al.
CIRCULATION (2004)
Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure
WT Abraham et al.
CIRCULATION (2004)
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
MR Bristow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay
A Auricchio et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure - The MIRACLE ICD Trial
JB Young et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients
P Agostoni et al.
CHEST (2002)
Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure
DW Kitzman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial
SD Hutcheon et al.
HEART (2002)
Cardiac resynchronization in chronic heart failure
WT Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: Analysis with magnetic resonance myocardial tagging
P Dubach et al.
AMERICAN HEART JOURNAL (2002)
Short-term intravenous milrinone for acute exacerbation of chronic heart failure - A randomized controlled trial
MS Cuffe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure -: a substudy to the MERIT-HF trial
L Gullestad et al.
EUROPEAN JOURNAL OF HEART FAILURE (2001)
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
S Cazeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Low-dose enoximone improves exercise capacity in chronic heart failure
BD Lowes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
MIC trial:: metoprolol in patients with mild to moderate heart failure:: effects on ventricular function and cardiopulmonary exercise testing
S Genth-Zotz et al.
EUROPEAN JOURNAL OF HEART FAILURE (2000)
Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy -: The randomized evaluation of strategies for left ventricular dysfunction pilot study
W Cirillo et al.
CIRCULATION (2000)
Share Paper
